基于生理学的药理动力学建模里托纳维尔-氧化的药物相互作用及其对剂量策略的影响
Liang Zheng1, Wei Zhang1, Klaus T Olkkola2
1Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
概括
里托纳维尔显著增加了氧化水平,造成了风险. 基于生理学上的药理动力学 (PBPK) 建模表明,在与利托纳维尔联合使用时,可以将氧化剂量减半或将间隔翻一番,以管理药物相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 计算生物学 计算生物学
背景情况:
- 同时使用利托纳维尔和氧可导致氧的血度显著增加.
- 了解这种药物相互作用 (DDI) 对患者安全至关重要.
研究的目的:
- 使用生理学基础药理动力学 (PBPK) 建模模拟里托纳维尔和氧化之间的DDI.
- 制定与里托纳维尔同时使用的氧化的剂量方案.
主要方法:
- 开发了一种利托纳维尔PBPK模型,用于CYP3A4诱导,抑制和CYP2D6抑制.
- 验证了与临床药理动力学数据相结合的利托纳维尔模型.
- 在各种剂量场景下模拟的氧化 - 里托纳维尔相互作用.
主要成果:
- 模型准确预测了利托纳维尔的药理动力学和其他药物 (米达佐拉姆,特里亚佐拉姆) 的暴露变化.
- 模拟显示,稳定状态氧化的度增加到166%和总暴露120%与利托纳维尔.
- 建议剂量调整:减半剂量或将氧化的剂量间隔增加一倍.
结论:
- 揭示了氧化 - 里托纳维尔相互作用的临床未研究的暴露风险.
- PBPK建模是指导药物相互作用中剂量调整的有效工具.
- 推的实用剂量策略,用于管理氧化-利托纳维尔联合治疗.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
40
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
40
One-Compartment Open Model for IV Bolus Administration: General Considerations
208
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
208
Pharmacokinetic Models: Overview
701
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
701
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
257
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
257
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
63
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
63
Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74


